MA52857A - Formulations ophtalmiques à base d'atropine - Google Patents

Formulations ophtalmiques à base d'atropine

Info

Publication number
MA52857A
MA52857A MA052857A MA52857A MA52857A MA 52857 A MA52857 A MA 52857A MA 052857 A MA052857 A MA 052857A MA 52857 A MA52857 A MA 52857A MA 52857 A MA52857 A MA 52857A
Authority
MA
Morocco
Prior art keywords
atropine
ophthalmic formulations
based ophthalmic
formulations
ophthalmic
Prior art date
Application number
MA052857A
Other languages
English (en)
Inventor
Danilo Aleo
Melina Cro
Sergio Mangiafico
Barbara MELILLI
Maria Grazia Saita
Fabiola Spitaleri
Original Assignee
Medivis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivis S R L filed Critical Medivis S R L
Publication of MA52857A publication Critical patent/MA52857A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052857A 2019-03-01 2019-03-01 Formulations ophtalmiques à base d'atropine MA52857A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19160293.7A EP3701938B8 (fr) 2019-03-01 2019-03-01 Formulations ophtalmiques à base d'atropine

Publications (1)

Publication Number Publication Date
MA52857A true MA52857A (fr) 2021-04-21

Family

ID=65903880

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052857A MA52857A (fr) 2019-03-01 2019-03-01 Formulations ophtalmiques à base d'atropine

Country Status (4)

Country Link
EP (1) EP3701938B8 (fr)
MA (1) MA52857A (fr)
PT (1) PT3701938T (fr)
WO (1) WO2020178689A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114588110B (zh) * 2022-03-25 2023-08-04 山西利普达医药科技有限公司 一种眼用药物乳剂组合物及其制备方法和应用
JP7884090B2 (ja) * 2022-09-11 2026-07-02 アルコン インク. ベンジルアトロピンを含む水性医薬組成物及びその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US20210267885A1 (en) 2016-05-25 2021-09-02 Singapore Health Services Ptel Ltd Atropine-containing aqueous composition
JP6789713B2 (ja) 2016-08-01 2020-11-25 キヤノン株式会社 画像形成装置及び制御方法
CN108338969A (zh) * 2018-02-08 2018-07-31 胡敏 一种低浓度托烷类药物滴眼液及其制备方法

Also Published As

Publication number Publication date
EP3701938A1 (fr) 2020-09-02
EP3701938B1 (fr) 2023-11-15
WO2020178689A1 (fr) 2020-09-10
PT3701938T (pt) 2024-01-31
EP3701938B8 (fr) 2024-02-21

Similar Documents

Publication Publication Date Title
EP3775202A4 (fr) Agents thérapeutiques à base d'acides nucléiques
EP3746090A4 (fr) Vaccins à base d'arn contre le vrs
EP3926701A4 (fr) Panneau d'affichage
EP3819300A4 (fr) Composition thérapeutique à base de biomarqueurs
EP3703672A4 (fr) Formulations à base de cannabinoïdes
EP3532240A4 (fr) Base d'outillage
MA52662A (fr) Conjugués d'il-2
EP3995553A4 (fr) Adhésif à base d'isocyanate
EP3919581A4 (fr) Composition d'agent adhésif à base d'uréthane
EP3993782A4 (fr) Compositions d'endoxifène à libération prolongée
EP3787641A4 (fr) Nettoyants de paupière à base d'acide hypochloreux
EP3683285A4 (fr) Composition adhésive à base d'uréthane
EP3919579A4 (fr) Composition adhésive à base d'uréthane
IL285674A (en) Pharmaceutical formulations
EP3735987A4 (fr) Conjugué d'anticorps à base d'amanitine
EP3986415A4 (fr) Formulations d'ibogaïne
EP3972610A4 (fr) Thérapie à base de mini-gènes
EP3982415A4 (fr) Panneau d'affichage
EP4030778A4 (fr) Casque d'écoute
EP3820980A4 (fr) Compositions d'esterquats
EP3963137A4 (fr) Coussinet d'appui
IL286663A (en) Hydrogel
EP4020945A4 (fr) Terminal d'affichage
EP3773574A4 (fr) Formulations d'amlodipine
EP3525772A4 (fr) Formulations destinées à l'administration entérique d'agents thérapeutiques